A detailed history of Mbb Public Markets I LLC transactions in Amgen Inc stock. As of the latest transaction made, Mbb Public Markets I LLC holds 39,618 shares of AMGN stock, worth $11.4 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
39,618
Previous 75,712 47.67%
Holding current value
$11.4 Million
Previous $23.7 Million 46.04%
% of portfolio
0.76%
Previous 0.49%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $11.2 Million - $12.2 Million
-36,094 Reduced 47.67%
39,618 $12.8 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $6.98 Million - $8.48 Million
26,553 Added 54.01%
75,712 $23.7 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $12.9 Million - $15.5 Million
47,820 Added 3571.32%
49,159 $14 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $6.65 Million - $7.5 Million
-26,000 Reduced 95.1%
1,339 $385,000
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $5.36 Million - $6.65 Million
-24,502 Reduced 47.26%
27,339 $7.35 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $6.9 Million - $8.16 Million
32,213 Added 164.12%
51,841 $11.5 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $4.19 Million - $5.1 Million
18,544 Added 1710.7%
19,628 $4.75 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $250,089 - $278,306
1,084 New
1,084 $264,000
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $1.2 Million - $1.33 Million
-5,494 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $1.09 Million - $1.25 Million
5,494 New
5,494 $1.24 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mbb Public Markets I LLC Portfolio

Follow Mbb Public Markets I LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbb Public Markets I LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbb Public Markets I LLC with notifications on news.